Home » FDA Warns API Manufacturer ChemPacific for Quality Issues
FDA Warns API Manufacturer ChemPacific for Quality Issues
The FDA has warned active pharmaceutical ingredient (API) manufacturer ChemPacific for GMP deviations, with citations related to documentation and written procedures.
Drug GMP Report
Drug GMP Report
Upcoming Events
-
07May
-
14May
-
30May